Concepedia

Solomon D. Kattar

SD

10

Publications

341

Citations

10

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Solomon D. Kattar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and natural sciences.

ORCID

Top concepts

Publications per year

2001–2023

10

Publications

10

Neurofilaments Consist of Distinct Populations That Can Be Distinguished by C-Terminal Phosphorylation, Bundling, and Axonal Transport Rate in Growing Axonal Neurites

Jason T. Yabe, Teresa M. Chylinski, Feng-Song Wang et al. · Journal of Neuroscience · 2001 · 110 citations · Full text

Piperazinyl pyrimidine derivatives as potent γ-secretase modulators

Alexey Rivkin, Sean P. Ahearn, Stephanie M. Chichetti et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 41 citations · Full text

, , +9

Discovery of a chemical probe for PRDM9

Abdellah Allali‐Hassani, Magdalena M. Szewczyk, Danton Ivanochko et al. · Nature Communications · 2019 · 41 citations · Full text

Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors

Mitchell H. Keylor, Anmol Gulati, Solomon D. Kattar et al. · Journal of Medicinal Chemistry · 2021 · 40 citations · Full text

Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization

Solomon D. Kattar, Laura Surdi, Anna A. Zabierek et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 27 citations · Full text

, , +11

Rows per page

1–5 of 10